Published in Transplantation on July 15, 2004
Portal vein thrombosis is a potentially preventable complication in clinical islet transplantation. Am J Transplant (2011) 1.10
Current status of islet cell transplantation. J Hepatobiliary Pancreat Surg (2008) 1.07
Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. Rev Diabet Stud (2012) 0.99
Islet cell transplantation. Postgrad Med J (2007) 0.88
Pancreatic islet transplantation. World J Gastrointest Surg (2009) 0.86
Encapsulated islets transplantation: Past, present and future. World J Gastrointest Pathophysiol (2012) 0.84
Trying to prevent the clogged drain: optimizing the yield and function of portal vein-infused islets. Dig Dis Sci (2013) 0.76
Islet transplantation in a recipient presenting the factor V Leiden mutation. Transplantation (2005) 0.75
Unexpected papilledema in a young male with Type 1 diabetes. Clin Case Rep (2017) 0.75
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog (2007) 8.01
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes (2004) 4.44
Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research. Transplantation (2008) 3.43
To nap or not to nap? Residents' work hours revisited. N Engl J Med (2009) 2.93
Increased islet apoptosis in Pdx1+/- mice. J Clin Invest (2003) 2.91
Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab (2009) 2.83
Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes (2002) 2.64
Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation (2003) 2.63
Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet (2005) 2.39
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation (2009) 2.33
Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant (2003) 2.22
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant (2005) 2.19
Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol (2009) 2.17
Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J Clin Invest (2004) 2.09
Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol (2004) 1.93
TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes (2009) 1.83
Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol (2003) 1.77
Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation (2009) 1.75
Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing. Virology (2012) 1.75
Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest (2003) 1.73
Living donation decision making: recipients' concerns and educational needs. Prog Transplant (2006) 1.73
Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant (2005) 1.73
Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Am J Physiol Endocrinol Metab (2003) 1.68
Visualizing superoxide production in normal and diabetic rat islets of Langerhans. J Biol Chem (2003) 1.65
Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc Natl Acad Sci U S A (2006) 1.63
Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes (2005) 1.62
Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes. Transplantation (2010) 1.57
Insulin sensitivity by oral glucose minimal models: validation against clamp. Am J Physiol Endocrinol Metab (2005) 1.50
Autophagy regulates pancreatic beta cell death in response to Pdx1 deficiency and nutrient deprivation. J Biol Chem (2009) 1.48
Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation (2015) 1.45
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial. J Infect Dis (2011) 1.42
The physician scientist training program in internal medicine at Washington University School of Medicine. Acad Med (2009) 1.41
Ca2+ controls slow NAD(P)H oscillations in glucose-stimulated mouse pancreatic islets. J Physiol (2006) 1.41
Carboxypeptidase E mediates palmitate-induced beta-cell ER stress and apoptosis. Proc Natl Acad Sci U S A (2008) 1.39
RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets. J Biol Chem (2004) 1.37
BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol (2007) 1.36
Standardization of C-peptide measurements. Clin Chem (2008) 1.36
Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant (2004) 1.33
Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet. J Biol Chem (2008) 1.31
High-molecular-weight polyethylene glycol prevents lethal sepsis due to intestinal Pseudomonas aeruginosa. Gastroenterology (2004) 1.28
BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol (2008) 1.25
Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance. Diabetes (2009) 1.24
Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22
The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation (2003) 1.22
Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol (2008) 1.21
Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes (2004) 1.18
Reduced expression of the insulin receptor in mouse insulinoma (MIN6) cells reveals multiple roles of insulin signaling in gene expression, proliferation, insulin content, and secretion. J Biol Chem (2004) 1.18
Weight loss therapy improves pancreatic endocrine function in obese older adults. Obesity (Silver Spring) (2008) 1.18
Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol (2010) 1.17
Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times. Diabetes (2002) 1.16
Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposure. Am J Kidney Dis (2009) 1.15
Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure. Transplantation (2006) 1.13
Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol (2006) 1.13
Targeting cyclophilin D and the mitochondrial permeability transition enhances beta-cell survival and prevents diabetes in Pdx1 deficiency. Proc Natl Acad Sci U S A (2010) 1.12
Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol (2005) 1.11
De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. Am J Kidney Dis (2005) 1.09
Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient. Arch Ophthalmol (2008) 1.09
In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. Transplantation (2006) 1.09
Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. FASEB J (2004) 1.08
Pathogenesis of nonimmune glomerulopathies. Annu Rev Pathol (2006) 1.08
Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation (2004) 1.07
Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation (2007) 1.06
Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation (2014) 1.04
Calpain system regulates muscle mass and glucose transporter GLUT4 turnover. J Biol Chem (2004) 1.04
Novel methods for tracking long-term maintenance immunosuppression regimens. Clin J Am Soc Nephrol (2007) 1.04
Inhibitory interactions between BK and JC virus among kidney transplant recipients. J Am Soc Nephrol (2011) 1.03
Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med (2008) 1.03
Suppressed insulin signaling and increased apoptosis in CD38-null islets. Diabetes (2006) 1.02
The role of tacrolimus in renal transplantation. Expert Opin Pharmacother (2008) 1.02
A significant role for histocompatibility in human islet transplantation. Transplantation (2006) 1.02
Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am Soc Nephrol (2008) 1.02
A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism (2003) 1.02
Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation (2002) 1.02
Loss of Nix in Pdx1-deficient mice prevents apoptotic and necrotic β cell death and diabetes. J Clin Invest (2010) 1.02
International comparison of C-peptide measurements. Clin Chem (2007) 1.01
Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients. Transplantation (2012) 1.01
Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46. J Immunol (2011) 1.01
Complex patterns of metabolic and Ca²⁺ entrainment in pancreatic islets by oscillatory glucose. Biophys J (2013) 1.01
The life-years saved by a deceased organ donor. Am J Transplant (2005) 1.00
Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism. J Biol Chem (2010) 1.00
The association of cytomegalovirus sero-pairing with outcomes and costs following cadaveric renal transplantation prior to the introduction of oral ganciclovir CMV prophylaxis. Am J Transplant (2003) 0.99
A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results. Transplantation (2008) 0.99
Kidney transplant Medicare payments and length of stay: associations with comorbidities and organ quality. Arch Med Sci (2011) 0.99
Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. Transpl Int (2004) 0.97
Ginseng and ginsenoside Re do not improve β-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes. Diabetes Care (2011) 0.97
Retinol-binding protein 4, insulin resistance, and type 2 diabetes. N Engl J Med (2006) 0.97
Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial. Transplantation (2007) 0.97
Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals. Diabetes (2005) 0.97
CMV infection of the renal allograft is much more common than the pathology indicates: a retrospective analysis of qualitative and quantitative buffy coat CMV-PCR, renal biopsy pathology and tissue CMV-PCR. Nephrol Dial Transplant (2003) 0.96
Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review. Transplantation (2008) 0.96
Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells. J Biomed Mater Res A (2008) 0.96
Late acute rejection after liver transplantation: the Western Canada experience. Liver Transpl (2002) 0.96